---
layout: ../../layouts/Publication.astro
title: Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.
journal: Molecular medicine (Cambridge, Mass.)
authors: Wilk EJ, Howton TC, Fisher JL, Oza VH, Brownlee RT, McPherson KC, Cleary HL, Yoder BK, George JF, Mrug M, Lasseigne BN
year: 2023
page: 67
volume: 29
issue: 1
pmid: 37217845.0
pmcid: PMC10201779
doi: 10.1186/s10020-023-00664-z
landmark: False
carousel: False
featured: False
r03: R03OD030604
keywords: ["Drug Repositioning", "ADPKD", "TRPP Cation Channels", "Gene Expression", "PKD", "Polycystic Kidney, Autosomal Dominant", "Mice", "Tolvaptan", "Drug repurposing", "LINCS", "Drug prioritization", "Polycystic kidney disease", "Signature reversion", "Polycystic Kidney Diseases", "Kidney", "Animals", "Humans"]
---